Compounds > angiotensin ii
Page last updated: 2024-08-22

angiotensin ii and calpastatin

angiotensin ii has been researched along with calpastatin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Sandmann, S; Unger, T; Yu, M1
Baud, L; Bellocq, A; de Castro Keller, A; Haymann, JP; Letavernier, E; Mesnard, L; Perez, J1
Balakrishnan, A; Baud, L; Chishti, AH; Howatt, DA; Moorleghen, JJ; Muniappan, L; Rateri, DL; Saido, TC; Subramanian, V; Takano, J; Uchida, HA1
Beckett, JD; Bedja, D; Butcher, JT; Chen, Y; Creamer, TJ; Dietz, HC; Gould, RA; Hata, S; Kim, DH; MacFarlane, EG; Mitzner, W; Nagpal, V; Rouf, R; Seman-Senderos, MA; Warren, DS1
Bensaada, I; Camus, M; Chipont, A; Guyonnet, L; Hénique, C; Lazareth, H; Lemoine, M; Lenoir, O; Letavernier, E; Perez, J; Robin, B; Salemkour, Y; Tharaux, PL1

Other Studies

5 other study(ies) available for angiotensin ii and calpastatin

ArticleYear
Transcriptional and translational regulation of calpain in the rat heart after myocardial infarction--effects of AT(1) and AT(2) receptor antagonists and ACE inhibitor.
    British journal of pharmacology, 2001, Volume: 132, Issue:3

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Calcium-Binding Proteins; Calpain; Disease Models, Animal; Gene Expression Regulation; Heart; Heart Rate; Imidazoles; Male; Myocardial Infarction; Protein Biosynthesis; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Tetrazoles; Transcription, Genetic; Valine; Valsartan

2001
Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension.
    Circulation research, 2008, Mar-28, Volume: 102, Issue:6

    Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Calcium-Binding Proteins; Calpain; Cysteine Proteinase Inhibitors; Disease Models, Animal; Fibrosis; Genetic Therapy; Hypertension; Hypertrophy; Hypertrophy, Left Ventricular; Inflammation; Infusion Pumps, Implantable; Mice; Mice, Transgenic; Muscle, Smooth, Vascular; Myocardium; NF-kappa B; NFATC Transcription Factors; Renal Artery; Time Factors; Ventricular Remodeling

2008
Leukocyte Calpain Deficiency Reduces Angiotensin II-Induced Inflammation and Atherosclerosis But Not Abdominal Aortic Aneurysms in Mice.
    Arteriosclerosis, thrombosis, and vascular biology, 2016, Volume: 36, Issue:5

    Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Atherosclerosis; Bone Marrow Transplantation; Calcium-Binding Proteins; Calpain; Cell Adhesion; Cell Movement; Cells, Cultured; Coculture Techniques; Cysteine Proteinase Inhibitors; Diet, High-Fat; Disease Models, Animal; Endothelial Cells; Genetic Predisposition to Disease; Inflammation; Leukocytes; Macrophages; Male; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Phenotype; Receptors, LDL; Whole-Body Irradiation

2016
Calpain 9 as a therapeutic target in TGFβ-induced mesenchymal transition and fibrosis.
    Science translational medicine, 2019, 07-17, Volume: 11, Issue:501

    Topics: Angiotensin II; Animals; Bleomycin; Calcium-Binding Proteins; Calpain; Carbon Tetrachloride; Cell Line; Dogs; Epithelial-Mesenchymal Transition; Fibrosis; Humans; Isoenzymes; Liver Cirrhosis; Male; Mice, Inbred C57BL; Molecular Targeted Therapy; Myocardium; Protein Biosynthesis; Protein Multimerization; RNA Stability; Signal Transduction; Transforming Growth Factor beta

2019
Calpastatin prevents Angiotensin II-mediated podocyte injury through maintenance of autophagy.
    Kidney international, 2021, Volume: 100, Issue:1

    Topics: Angiotensin II; Animals; Autophagy; Calcium-Binding Proteins; Kidney Glomerulus; Mice; Podocytes

2021